Nuclear Medicine Equipment Market Analysis Report 2024-2030
November 04, 2024 06:50 ET
|
Research and Markets
Dublin, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The "Nuclear Medicine Equipment Market Size, Share and Trends Analysis Report by Type (SPECT, PET, Planar Scintigraphy Systems), Application (Oncology,...
Claritas NucMed Receives Clearance from Brazilian Regulator ANVISA to Market Claritas iPET™ Software Enabling Reduced Scan Time and Reduced Isotope Dosage in PET-CT/MRI Scans
October 29, 2024 06:45 ET
|
Claritas HealthTech Ltd
NEW YORK and LONDON and SAO PAOLO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Claritas NucMed Tech Brazil S.A. (“Claritas NucMed Brazil”), a subsidiary of UK-based Claritas NucMed Technologies Ltd (“Claritas...
Die ICPO Foundation förderte durch einen Grant den globalen „Radiopharmaceutical Trial Finder“, entwickelt von WARMTH und Ancora.ai
October 16, 2024 07:00 ET
|
ICPO Foundation
Dieses bahnbrechende, KI-gestützte Tool zur globalen Studienfindung wird auf dem EANM-Kongress 2024 in Hamburg vom 20. bis 22. Oktober 2024 vorgestellt. 16. Oktober 2024 – Wiesbaden, Deutschland und...
ICPO Foundation funded global “Radiopharmaceutical Trial Finder” developed by WARMTH and Ancora.ai
October 16, 2024 07:00 ET
|
ICPO Foundation
This pioneering global trial finder tool powered by AI will be presented at the EANM Congress 2024 in Hamburg from Oct 20-22, 2024 October 16, 2024 – Wiesbaden, Germany and Zurich, Switzerland....
ICPO Foundation geht eine Partnerschaft mit der International Atomic Energy Agency (IAEA) ein
October 10, 2024 04:15 ET
|
ICPO Foundation
Die Parteien kooperieren weltweit im Bereich der therapeutischen klinischen Anwendungen der Nuklearmedizin in der Onkologie. 10. Oktober 2024 – Wiesbaden, Deutschland. Heute kündigte die...
ICPO Foundation partners with the International Atomic Energy Agency (IAEA)
October 10, 2024 04:15 ET
|
ICPO Foundation
The parties cooperate in the area of therapeutic clinical applications of nuclear medicine in oncology worldwide. October 10, 2024 – Wiesbaden, Germany. Today, the International Centers for...
Curium Announces the Official Opening its New Netherlands Facility for the Production of Lutetium-177 – a Game Changer Therapy Isotope for Cancer Patients Worldwide
September 24, 2024 08:45 ET
|
Curium
Curium opens new Netherlands facility for Lu-177 production, ensuring a steady supply of this breakthrough cancer therapy isotope for over 100,000 patients
Lutetium-177 Industry Research Report 2024: Carrier Added Lutetium-177, Non-Carrier-Added Lutetium-177 - Global Forecast 2024-2030
September 09, 2024 04:56 ET
|
Research and Markets
Dublin, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The "Lutetium-177 Market by Form (Carrier Added Lutetium-177, Non-Carrier-Added Lutetium-177), Route of Administration (Intravenous, Oral), End User,...
Claritas NucMed Technologies Secures Approval for its Subsidiary Claritas NucMed Tech Brazil to Forge Ahead the Commercialization of its Cutting-Edge Nuclear Medicine Software Solutions in Brazil
September 02, 2024 10:00 ET
|
Claritas HealthTech Ltd
Claritas NucMed Technologies Secures Approval for its Subsidiary Claritas NucMed Tech Brazil to Forge Ahead the Commercialization of its leading SaMDs
North America $3.62 Bn Nuclear Medicine Market by Country, Competition, Forecast & Opportunities, 2019-2023 & 2024-2029
August 26, 2024 10:52 ET
|
Research and Markets
Dublin, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The "North America Nuclear Medicine Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ...